Dermatology Times e-News:
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
|
to Dermatology Times e-News
|
|
|
|
|
|
FYI ...
114,900
Estimate of new cases of melanoma in the United States in 2010.
Source: American Academy of Dermatology.
|
|
|
|
Botox reduces pain in mice
Seoul, South Korea — Botulinum neurotoxin type A (BoNT/A; onabotulinumtoxinA, Botox, Allergan) reduces responses to an inflammation-related pain stimulus when injected into the spinal canal in mice, according to a new study reported by Newswise.com. Read full article. |
 |
|
|
Parents favor genetic test
Salt Lake City — The vast majority of parents who tested positive for a genetic mutation that increases the risk of melanoma support genetic testing of their children and grandchildren, Newswise.com reports. Read full article.
|
|
CDC adds wart therapy option
Florham Park, N.J. — PharmaDerm, based here, has announced that its Veregen Ointment (sinecatechins, 15 percent), a topical medication for the treatment of external genital and perianal warts, has been added as a new therapeutic option in the 2010 Centers for Disease Control and Prevention (CDC) Sexually Transmitted Diseases Treatment Guidelines, PRNewswire reports. Read full article.
|
|
Baldness linked to stem cells
Philadelphia — An inability of scalp stem cells to develop into the type of cells that make hair follicles may be an underlying cause of male-pattern baldness, msnbc.com reports. Read full article.
|
|
Aussies know little about skin
Sydney — Only 25 percent of Australian adults over 40 were able to identify the skin as an organ without prompting, Australia’s HeraldSun.com.au reports. Read full article.
|
|
Careers
|
|
|
|
Contact Us |
Contact a Dermatology Times editor Click Here
Contact a Dermatology Times sales representative Click Here
Learn about direct mail, reprints and classifieds in Dermatology Times Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
